Optimal Quantification of THC in Blood

Importance of the Topic

The reliable measurement of delta-9-tetrahydrocannabinol (Δ9-THC) and its primary metabolite THC-COOH in blood is critical for enforcing driving under the influence laws and assessing recent cannabis exposure. As legal limits vary by jurisdiction, analytical methods must achieve sensitivity below the strictest thresholds.

Objectives and Study Overview

This application note presents a validated gas chromatography-mass spectrometry (GC-MS) method for quantifying Δ9-THC and THC-COOH in whole blood. The work aims to demonstrate instrument performance, detection limits, linearity, and repeatability to meet or exceed legal requirements in the United Kingdom, Canada, and France.

Methodology and Instrumentation

Samples were processed by adding deuterated internal standards (Δ9-THC-D3 and THC-COOH-D3) to blood, followed by protein precipitation with acetic acid, liquid–liquid extraction using hexane/ethyl acetate, evaporation, and derivatization with BSTFA+1% TCMS. A 2 µL aliquot was injected in splitless mode.

• Gas chromatograph: SCION 456 GC
• Mass spectrometer: SCION Single Quadrupole MS
• Column: SCION-5MS, 15 m × 0.25 mm × 0.25 µm
• Injector temperature: 280 °C (splitless)
• Oven program: 50 °C (0.1 min), ramp 15 °C/min to 260 °C, then 20 °C/min to 300 °C
• Carrier gas: Helium at 1 mL/min
• Ionization: 70 eV, positive mode
• Monitored ions: Δ9-THC (371, 386), THC-COOH (371, 473)

Main Results and Discussion

Calibration was linear across 0.5–10 ng/mL for Δ9-THC and 2.5–50 ng/mL for THC-COOH. Limits of detection (LOD) were 0.2 ng/mL for Δ9-THC and 2.5 ng/mL for THC-COOH, with limits of quantification (LOQ) of 0.5 ng/mL and 2.5 ng/mL respectively. Repeatability (n=5) and reproducibility (n=10) tests at low concentration levels yielded relative standard deviations below 7%, demonstrating robust performance. Overlay of multiple injections confirmed retention time stability and consistent signal intensity.

Benefits and Practical Applications

The method surpasses legal quantification limits in key jurisdictions and offers a straightforward workflow suitable for forensic and clinical laboratories. High sensitivity and reproducibility make it ideal for confirmation of roadside screening and long-term use assessment.

Future Trends and Applications

Advances may include coupling to tandem MS for enhanced selectivity, implementation of high-resolution mass spectrometry, and automation of sample preparation to increase throughput. Portable or miniaturized GC‐MS devices could enable on-site testing. Expanding the method to additional biomarkers will improve comprehensive drug use profiling.

Conclusion

This study demonstrates a reliable GC-MS protocol for the accurate quantification of Δ9-THC and THC-COOH in blood. The validated LODs, LOQs, and quality metrics meet stringent legal requirements, offering forensic and clinical analysts a robust tool for cannabis exposure assessment.

Reference

1. United Nations Office on Drugs and Crime 2017 Statistics and Trends in Illicit Drugs